Your browser doesn't support javascript.
loading
Correction to: Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: an international prospective cohort of BRCA1 and BRCA2 mutation carriers.
Mavaddat, Nasim; Antoniou, Antonis C; Mooij, Thea M; Hooning, Maartje J; Heemskerk-Gerritsen, Bernadette A; Noguès, Catherine; Gauthier-Villars, Marion; Caron, Olivier; Gesta, Paul; Pujol, Pascal; Lortholary, Alain; Barrowdale, Daniel; Frost, Debra; Evans, D Gareth; Izatt, Louise; Adlard, Julian; Eeles, Ros; Brewer, Carole; Tischkowitz, Marc; Henderson, Alex; Cook, Jackie; Eccles, Diana; van Engelen, Klaartje; Mourits, Marian J E; Ausems, Margreet G E M; Koppert, Linetta B; Hopper, John L; John, Esther M; Chung, Wendy K; Andrulis, Irene L; Daly, Mary B; Buys, Saundra S; Benitez, Javier; Caldes, Trinidad; Jakubowska, Anna; Simard, Jacques; Singer, Christian F; Tan, Yen; Olah, Edith; Navratilova, Marie; Foretova, Lenka; Gerdes, Anne-Marie; Roos-Blom, Marie-José; Van Leeuwen, Flora E; Arver, Brita; Olsson, Håkan; Schmutzler, Rita K; Engel, Christoph; Kast, Karin; Phillips, Kelly-Anne.
Afiliação
  • Mavaddat N; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, Strangeways Research Laboratory, Worts Causeway, University of Cambridge, Cambridge, CBI 8RN, UK. nm274@medschl.cam.ac.uk.
  • Antoniou AC; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, Strangeways Research Laboratory, Worts Causeway, University of Cambridge, Cambridge, CBI 8RN, UK.
  • Mooij TM; Department of Epidemiology, Netherlands Cancer Institute, P.O. Box 90203, 1006 BE, Amsterdam, The Netherlands.
  • Hooning MJ; Department of Medical Oncology, Family Center Clinic, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
  • Heemskerk-Gerritsen BA; Department of Medical Oncology, Family Center Clinic, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
  • Noguès C; DASC, Oncogénétique Clinique, Institut Paoli-Calmettes, Marseille, France.
  • Gauthier-Villars M; Institut Curie, Service de Génétique, Paris, France.
  • Caron O; Département de Médecine Oncologique, Gustave Roussy Hôpital Universitaire, Villejuif, France.
  • Gesta P; Centre Hospitalier, Service Régional d'Oncologie Génétique Poitou-Charentes, Niort, France.
  • Pujol P; Unité d'Oncogénétique, CHU Arnaud de Villeneuve, Montpellier, France.
  • Lortholary A; Centre Catherine de Sienne, Service d'Oncologie Médicale, Nantes, France.
  • Barrowdale D; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, Strangeways Research Laboratory, Worts Causeway, University of Cambridge, Cambridge, CBI 8RN, UK.
  • Frost D; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, Strangeways Research Laboratory, Worts Causeway, University of Cambridge, Cambridge, CBI 8RN, UK.
  • Evans DG; Genomic Medicine, Manchester Academic Health Sciences Centre, Division of Evolution and Genomic Sciences, Manchester University, Central Manchester, University Hospitals NHS Foundation Trust, Manchester, UK.
  • Izatt L; Clinical Genetics, Guy's and St Thomas' NHS Foundation Trust, London, UK.
  • Adlard J; Yorkshire Regional Genetics Service, Chapel Allerton Hospital and University of Leeds, Leeds, UK.
  • Eeles R; Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London, UK.
  • Brewer C; Department of Clinical Genetics, Royal Devon & Exeter Hospital, Exeter, UK.
  • Tischkowitz M; Academic Department of Medical Genetics, National Institute for Health Research Cambridge Biomedical Research Centre, University of Cambridge, Cambridge, UK.
  • Henderson A; Institute of Genetic Medicine, Centre for Life, Newcastle Upon Tyne Hospitals NHS Trust, Newcastle upon Tyne, UK.
  • Cook J; Sheffield Clinical Genetics Service, Sheffield Children's Hospital, Sheffield, UK.
  • Eccles D; University of Southampton Faculty of Medicine, Southampton University Hospitals NHS Trust, Southampton, UK.
  • van Engelen K; Department of Clinical Genetics, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands.
  • Mourits MJE; Department of Gynaecological Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
  • Ausems MGEM; Department of Genetics, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Koppert LB; Department of Surgical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
  • Hopper JL; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, VIC, 3010, Australia.
  • John EM; Department of Medicine and Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.
  • Chung WK; Departments of Pediatrics and Medicine, Columbia University Medical Center, New York, NY, USA.
  • Andrulis IL; Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, NY, USA.
  • Daly MB; Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.
  • Buys SS; Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, Ontario, Canada.
  • Benitez J; Department of Medicine, Huntsman Cancer Institute, University of Utah Health Sciences Center, Salt Lake City, UT, USA.
  • Jakubowska A; Human Genetics Group and Genotyping Unit, CEGEN, Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
  • Simard J; Molecular Oncology Laboratory, Hospital Clinico San Carlos, IdISSC, CIBERONC (ISCIII), Madrid, Spain.
  • Singer CF; Department of Genetics and Pathology, Pomeranian Medical University, Unii Lubelskiej 1, Szczecin, Poland.
  • Tan Y; Independent Laboratory of Molecular Biology and Genetic Diagnostics, Pomeranian Medical University, Unii Lubelskiej 1, Szczecin, Poland.
  • Olah E; Genomics Center, Centre Hospitalier Universitaire de Québec, Université Laval Research Center, 2705 Laurier Boulevard, Quebec City, Quebec, Canada.
  • Navratilova M; Department of OB/GYN and Comprehensive Cancer Center, Medical University of Vienna, Waehringer Guertel 18-20, A 1090, Vienna, Austria.
  • Foretova L; Department of OB/GYN and Comprehensive Cancer Center, Medical University of Vienna, Waehringer Guertel 18-20, A 1090, Vienna, Austria.
  • Gerdes AM; Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary.
  • Roos-Blom MJ; Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Zluty kopec 7, 65653, Brno, Czech Republic.
  • Van Leeuwen FE; Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Zluty kopec 7, 65653, Brno, Czech Republic.
  • Arver B; Department of Clinical Genetics, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
  • Olsson H; Department of Epidemiology, Netherlands Cancer Institute, P.O. Box 90203, 1006 BE, Amsterdam, The Netherlands.
  • Schmutzler RK; Department of Epidemiology, Netherlands Cancer Institute, P.O. Box 90203, 1006 BE, Amsterdam, The Netherlands.
  • Engel C; The Department of Oncology and Pathology, Karolinska Institute, 171 76, Stockholm, Sweden.
  • Kast K; Department of Oncology, Lund University Hospital, Lund, Sweden.
  • Phillips KA; Department of Oncology, Lund University Hospital, Lund, Sweden.
Breast Cancer Res ; 22(1): 25, 2020 Feb 26.
Article em En | MEDLINE | ID: mdl-32102695
ABSTRACT
After publication of the original article [1], we were notified that columns in Table 2 were erroneously displayed.
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Risk_factors_studies Idioma: En Revista: Breast Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Risk_factors_studies Idioma: En Revista: Breast Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Reino Unido